Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Investors’ Appetite For Aardvark Wanes After $94.2m IPO

GH Research, Oculis Price Follow-On Offerings

Feb 17 2025

• By Mandy Jackson

Finance Watch Public Company — • Source: Alamy

Related Content

Sionna IPO Grosses $191m To Compete With Vertex In CF

Feb 07 2025

Sarepta Bullish After Another Big Beat For Elevidys

Jan 14 2025

CEO Viehbacher Confident In Biogen’s Portfolio, But Open To Additions

Feb 13 2025

GH’s Phase IIb Data Show Potential Differentiation In Depression

Feb 03 2025

Aligos’s MASH Data Look Competitive, But Path Forward Is Unclear

Sep 19 2024

Oculis Eyes Opportunities For Third Ophthalmology Candidate

Jan 06 2025

Related Companies

Aardvark Therapeutics, Inc.

Sarepta Therapeutics, Inc.

Biogen, Inc.

Royalty Pharma plc

Sionna Therapeutics, Inc.

GH Research plc

Aligos Therapeutics, Inc.

Oculis S.A.

Additional Topics

Financing Business Strategies

More from Finance Watch

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window